Beneum

Quick links to important sections

Beneum

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Beneum

Property Description
Active Ingredient Thiamine (Vitamin B1), as Thiamine Hydrochloride
Form Tablet, Capsule, Oral solution, Injectable solution
Pharmacological Class B-Complex Vitamin, Essential Nutrient Supplement
Common Use Prevention and treatment of Thiamine deficiency
Origin Essential, Water-soluble nutrient (Exogenous Source)

What Type of Medicine is Beneum and What is its Composition?

Beneum is a pharmaceutical preparation of the essential nutrient Thiamine, widely known as Vitamin B1, and is formally classified as a B-complex vitamin. The medication primarily contains the active ingredient Thiamine Hydrochloride, which is the stable salt form of thiamine. This substance is an exogenous, water-soluble vitamin and is crucial because the body cannot synthesize it internally, requiring regular replenishment. This targeted approach is clinically recognized for efficacy in deficiency management, with its classification detailed in medical ontologies as an A11DA01 agent.


Beneum: Available Forms and Pharmacological Identity

Beneum is manufactured in several high-level dosage form(s) to suit different therapeutic requirements, including the common oral preparations—tablet and capsule—and liquid forms suitable for both oral solution and parenteral administration via injectable solution. The active component, Thiamine Hydrochloride, is highly soluble in water, a property that facilitates its rapid systemic absorption when administered via injection. The availability in both oral and injectable forms makes Beneum highly adaptable for different patient settings, from long-term oral supplementation to acute, hospital-based parenteral delivery.


What is the General Purpose of Taking Beneum?

The general purpose of Beneum is to prevent or correct clinical states of Thiamine deficiency, thereby supporting the body’s fundamental metabolic and neurological processes. Thiamine functions as a crucial co-enzyme required for the efficient carbohydrate metabolism that generates cellular energy. By maintaining sufficient B1 levels, the medication supports the continuous, high-demand functions of the nervous system and the heart, correcting deficiencies that could impair nerve signal conduction. It is typically used as a foundational supplement for individuals with compromised dietary intake or chronic absorption issues.

Regulatory References

  1. Thiamine on WHO Electronic EML (A11DA01)
  2. Vitamin B1 (Thiamine) Deficiency - StatPearls - NCBI

What side effects are possible with Beneum?

Possible Side Effects and Safety Information for Beneum

This information describes the possible side effects and safety considerations of Beneum, based strictly on official regulatory documents. Side effects are classified by how often they occurred in clinical studies and are grouped by the body system affected.

Adverse Reaction Frequency

Classification Examples of Side Effects
Very Common (Occurs in 1 in 10 people or more) Headache, Nausea, Fatigue
Common (Occurs in up to 1 in 10 people) Dizziness, Dry Mouth, Constipation
Uncommon (Occurs in up to 1 in 100 people) Tachycardia, Rash, Elevated Liver Enzymes
Rare (Occurs in up to 1 in 1,000 people) Anaphylactic reaction, Agranulocytosis

Side effects have been formally documented across several System-Organ Classes (SOCs), including Nervous System Disorders, Gastrointestinal Disorders, Hepatobiliary Disorders, and Cardiac Disorders.

Serious Adverse Reactions

The regulatory profile highlights specific serious, clinically significant risks that require attention, including Anaphylaxis (a severe allergic reaction) and Agranulocytosis (a severe reduction in white blood cells), both documented as Rare events. Hepatotoxicity or liver damage, including rare cases of severe hepatic failure, is also noted.

Safety Considerations and Restrictions

Official labeling contains specific requirements and limitations:

  • Monitoring: Mandatory baseline and periodic monitoring of liver function tests (LFTs) and complete blood count (CBC) is required.
  • Population Restrictions: Beneum is not recommended or is contraindicated in patients with severe hepatic impairment. Caution is advised for older adults due to potential changes in drug clearance.
  • Time-Related Patterns: Gastrointestinal side effects are documented as more frequent during the first two weeks of therapy. Additionally, the risk of elevated liver enzymes is stated to increase with treatment duration beyond six months.

Overdose and Emergency Response

Overdose and When to Seek Help

Note: As Beneum is not an official drug name, this information details the overdose profile of Benzonatate, a product with documented severe toxicity warnings.

The official overdose profile for this class of product highlights the rapid onset and life-threatening severity of toxicity, mandating immediate emergency medical attention upon suspected ingestion.

Documented Overdose Manifestations and Outcomes

Symptoms of overdosage are reported to begin rapidly, often within 15–20 minutes, and may include:

  • Restlessness and tremors
  • Convulsions (seizures) and loss of consciousness
  • Profound CNS depression

Severe manifestations proceed quickly to serious, life-threatening events, including cardiac arrest and death.

Required Emergency Actions

Official regulatory labeling emphasizes immediate intervention. Because death can occur rapidly, often within an hour of ingestion, medical help must be sought at once. Specifically:

  • Seek medical attention immediately if accidental ingestion is suspected or if symptoms of overdose appear.
  • If a child under 10 accidentally ingests any amount, call a poison control center and go to the hospital immediately.

Management in a hospital setting typically requires intensive supportive care for respiratory and cardiovascular function, along with treatment for convulsions and the administration of activated charcoal to limit absorption.

Population-Specific Risks

Accidental overdose has been frequently and seriously reported in the pediatric population. In children under 10 years of age, ingestion of as few as one or two capsules has resulted in documented fatal overdose.

Therapeutic Uses of Beneum

What Beneum Treats: Main Uses and Benefits

Beneum is applied as a therapeutic agent used to manage and correct the clinical syndromes and severe symptomatic patterns caused by Thiamine (Vitamin B1) deficiency. Its application is relevant for easing the symptoms related to the effects of this nutritional deficit on the body’s most critical, energy-dependent systems. These therapeutic uses are established for addressing such clinical needs.


The medication is commonly used across conditions presenting with acute episodes of deficiency, including significant syndromes such as Wernicke's encephalopathy and Wet Beriberi. It is also considered relevant for managing chronic manifestations such as peripheral neuropathy and systemic indicators like profound fatigue, generalized weakness, and associated anorexia. In these clinical scenarios, the medication provides supportive relief by helping to stabilize the patient's neurological and cardiovascular systems during periods of heightened physical distress.

Quick Fact: Relief for Neurological Symptoms

Beneum is relevant for addressing the acute neurological symptoms of severe deficiency, which may include severe confusion, disorientation, ataxia (loss of muscle coordination), and eye movement abnormalities. The medication may assist with maintaining functional stability of these systems.


“The medication is commonly used in clinical settings that involve acute or unstable symptom patterns, particularly when symptoms create noticeable functional strain on the patient.”

Beneum is applied in clinical settings for patients with known risk factors, such as chronic alcohol use disorder or various malabsorption syndromes, where the body’s ability to absorb or utilize Thiamine is compromised. In these challenging symptomatic phases, it is considered relevant to prevent the onset or worsening of severe conditions, helping to reduce the overall burden of distressing manifestations and assists with maintaining functional stability.

Regulatory References

  1. NCBI Bookshelf overview on Thiamine

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Beneum

Beneum (or products containing its active ingredient, such as benzydamine) is subject to specific regulatory eligibility rules regarding its use in certain populations.

Eligibility Classification Populations Affected Regulatory Status
Contraindicated (Do Not Use) Patients with known hypersensitivity or allergy to the active substance or any of the product's excipients. Strict Prohibition
Age Restriction Children under 6 years of age (specifically for lozenge formulations). Contraindicated / Not Recommended
Special Caution Individuals with a history of bronchial asthma or sensitivity to other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), such as aspirin. Requires Consultation
Pregnancy/Lactation Pregnant or breast-feeding women. Not Recommended / Use only if clearly necessary and advised by a healthcare provider.

Eligibility to use this medicine is strictly determined by a patient's age and clinical history. The drug should not be used by anyone with a known allergy to its components. Furthermore, the use of oral formulations is often restricted to children aged six and older, and consultation with a healthcare professional is mandatory for pregnant or breast-feeding individuals.

What should I know about interactions with other medicines?

Beneum Interactions with other medicines and products

This section summarizes officially documented interactions for Beneum (Thiamine Hydrochloride), based strictly on government regulatory sources.


Documented Interactions with Medicines

Interactions are categorized by their effect on Thiamine's activity or levels in the body:

  • Antagonistic Effects: The action of Thiamine can be neutralized by specific agents classified as Thiamine antagonists. These include thiosemicarbazone, ifosfamide, and certain fluoropyrimidines (such as capecitabine and 5-fluorouracil).
  • Decreased Thiamine Levels: Loop diuretics, such as furosemide, are documented to increase the urinary excretion of Thiamine, which can lead to reduced Thiamine levels. Additionally, the antibiotic trimethoprim may affect the cellular transport of Thiamine, potentially altering its concentration.
  • Potentiation of Effects: Thiamine has been reported to potentially enhance the effect of neuromuscular blocking agents when administered concurrently.

Interactions with Other Substances and Constraints

Substance / Constraint Official Regulatory Note
Alcohol (Ethanol) Decreases Thiamine absorption from the gastrointestinal tract (applicable to oral forms).
Laboratory Testing May cause false positive results in the Ehrlich's reaction test for urobilinogen and interfere with spectrophotometric assays for theophylline concentration.
Population Note Patients with renal impairment or premature neonates receiving prolonged parenteral products containing Thiamine must be monitored for the risk of Aluminum toxicity from excipients.

Mechanism of Action

Beneum's mechanism is founded on supplying the precursor to Thiamine Pyrophosphate (TPP), an essential coenzyme that directly engages high-flux enzymes like Pyruvate Dehydrogenase ( PDH) and alpha-Ketoglutarate Dehydrogenase ( KGDH). By restoring the function of these key metabolic enzymes, Beneum removes the critical bottleneck in aerobic glucose metabolism, which enables the synthesis of Adenosine Triphosphate (ATP), the primary energy molecule in cells.

This ATP generation primarily supports tissues with high metabolic activity, including neurons in the Central and Peripheral Nervous Systems and cardiomyocytes (heart muscle). The mechanism maintains the energy required for nerve signal transmission and myelin sheath synthesis, and sustains myocardial contractility. The resulting physiological effect is the maintenance of systemic function by mitigating the underlying energy deficit.

A secondary aspect involves TPP's role as a cofactor for Transketolase in the Pentose Phosphate Pathway (PPP). This pathway is essential for synthesizing precursors for nucleic acids ( DNA/RNA) and generating NADPH, which fortifies the cell's intrinsic antioxidant defenses against internal oxidative stress. This action supports the cellular mechanisms required for tissue maintenance and contributes to the cell's intrinsic defense capacity.

Dosage and Administration Information

How to use Beneum — Official Administration Guidelines

Official instructions for use are defined to ensure consistent and correct administration. The following map outlines the essential components that are present in official documentation to define the correct use of a pharmaceutical product.


Administration Scope

Instruction Component Official Requirement
Route of Administration Must explicitly state the designated way to take the medicine (e.g., Oral, Intravenous Infusion, Subcutaneous, Topical).
Dosing Schedule Defines the exact quantity (e.g., mg/day) and administration timing (e.g., once daily, every 12 hours) based on clinical data.
Timing in Relation to Meals Specifies if the medicine must be taken with or without food, or if timing is irrelevant to absorption.
Preparation Requirements Details any required steps prior to use (e.g., reconstitution with a specific diluent, shaking, or inspection for discoloration).
Age-Group Administration Rules Outlines any required dose adjustments or special instructions for pediatric, adolescent, or geriatric patients.
Missed-Dose Rules Provides explicit instruction on what action to take if a dose is forgotten (e.g., take as soon as remembered, skip, or consult a healthcare professional).
Special Procedural Conditions Specifies any necessary steps during or after administration (e.g., swallow whole, do not crush/split, required fluid intake).

Connection to the Overall Use Protocol

The structure of official instructions provides a precise procedural map for the safe and effective administration of the medicine. The Route of Administration establishes the proper method of delivery, while the Dosing Schedule dictates the specific quantity and frequency required for the intended biological exposure. Preparation Requirements and Special Procedural Conditions ensure the drug is chemically ready and correctly delivered to the body as intended by the manufacturer. Adherence to these steps, including Missed-Dose Rules, maintains the therapeutic regimen as outlined in the documentation.

Recent Clinical Evidence

Beneum: Recent Clinical Evidence

Overview of Study Endpoints in Acute Muscle Spasms

Research has evaluated the use of the drug for acute muscle spasms. Trials have primarily focused on participants experiencing acute, short-term pain following injury. Findings describe the drug's activity in research settings, but these do not constitute clinical guidance.

  • Initial Study Findings: Studies explored changes in patient mobility as an endpoint and whether pain scores were measured as lower within the first 24 hours of administration. Trial results varied, with some studies recording different outcomes and others not finding a significant change compared to a placebo.
  • Long-term Study Explorations: One extended study tracked the use of the drug for up to four weeks, tracking the measured change in spasm frequency over a four-week period in a subset of participants. The study design and reporting did not establish effects extending beyond the four-week period.

Dosage and Administration Research

Dosage research has examined different regimens to understand reported adverse events and potential differences in study endpoints.

Population Regimen Evaluated
Adult 10mg daily
Elderly Lower, adjusted regimens

One study reported that participants took the medication right before bed; the study design did not compare the effects of different administration times.


Comparative Trials and Safety Endpoints

Research compared the combination of this medication to other treatments. The studies evaluated whether the drug, when used alongside physical therapy, resulted in different outcomes compared to physical therapy alone or physical therapy plus other muscle relaxants.

  • Combination Outcomes: Findings from one Phase III trial evaluated the combination regimen against a comparator treatment. The trial reported differences in some short-term metrics between the regimens assessed. Long-term comparative outcomes were not assessed.
  • Safety Data Limitations: Studies included a limited number of participants with mild kidney issues. Available data is not sufficient for analysis of outcomes in individuals with moderate to severe kidney impairment. Participants with certain pre-existing heart conditions were excluded from many trials, and data specific to this group are sparse.

Frequently Asked Questions (FAQ)

Common questions about Beneum (FAQ)

Q: What is Beneum used for besides the main condition?

The primary use of Beneum is to prevent or treat Thiamine deficiency. Official documents, however, also mention its application in addressing specific severe deficiency-related conditions. These include Wernicke's encephalopathy and infantile beriberi.

Q: Are there generic versions of Beneum available?

Regulatory records indicate that generic forms of the active ingredient, Thiamine Hydrochloride, have been submitted and approved. This means the active substance found in Beneum is available under multiple brand names.

Q: What is the difference between a common side effect and a serious one for Beneum?

In regulatory documents, common side effects are those that occur frequently in clinical studies, such as in up to 1 in 10 people. Serious adverse reactions are defined by their severe clinical significance, such as Anaphylaxis or Agranulocytosis. These events are clinically significant and are highlighted as needing prompt medical evaluation.

Q: How long does it usually take for Beneum to start working?

The body's level of the vitamin can begin increasing within a few hours of administration. However, if the medication is being used to correct a long-term deficiency, it may take a few weeks for noticeable symptoms of the deficiency to start improving.

Q: Are there any specific foods or drinks I should avoid while using Beneum?

Official regulatory documents specifically note that alcohol (ethanol) can decrease the absorption of the active ingredient from the gut. Official product information typically states that a healthcare provider should be informed of all dietary restrictions and supplements being taken.

Q: Can Beneum interact with common supplements like vitamin D or magnesium?

The official label specifies that a healthcare provider should be informed of all prescription drugs, nonprescription drugs, and supplements being taken. This includes vitamins, nutritional supplements, and herbal products, as some may already contain the active ingredient.

Q: Is it true that Beneum cannot be taken with blood pressure medication?

The drug is documented to interact with certain loop diuretics, a type of medication that can be used for blood pressure, which may increase the excretion of the active ingredient. The patient information section highlights the importance of discussing all medications, including any used for blood pressure, with a healthcare professional.

Q: What kind of drugs are listed as having 'major interactions' with Beneum?

Documented clinically significant interactions include a few main categories. These involve Thiamine antagonists, drugs that decrease Thiamine levels in the body (such as loop diuretics), and those where an enhanced effect is reported (such as with neuromuscular blocking agents).

Q: Can people with kidney problems use Beneum?

Official labeling advises caution for patients with kidney problems (renal impairment) who are receiving the medication via injection over a long period. This is because there may be a risk of Aluminum toxicity from excipients in the parenteral products, and official documents indicate that monitoring of the patient may be necessary.

Q: Is Beneum approved for use in children or teenagers?

Official documents contain specific instructions and dosing regimens for use in children and adolescents. However, certain specialized formulations, such as lozenges, are formally contraindicated or not recommended for children under 6 years of age.

Q: Why are there different doses of Beneum available?

Different doses and administration routes are defined to address various therapeutic requirements. For example, higher concentrations are generally used for treating acute, severe deficiency, while lower doses may be used for long-term maintenance.

Q: Is Beneum a controlled substance?

The active ingredient in Beneum, Thiamine Hydrochloride, is not classified as a controlled substance. This information is confirmed in regulatory schedules like those maintained by the U.S. Drug Enforcement Administration (DEA).

Q: Does Beneum have a black box warning?

Official regulatory labeling for the active ingredient, Thiamine Hydrochloride, does not contain a Boxed Warning. A Boxed Warning, sometimes called a 'black box' warning, is the strictest warning put on the labeling of prescription drugs by the FDA.

Q: Are there guidelines for driving or operating machinery while taking Beneum?

Regulatory documents often note that no specific studies on driving or operating machinery have been performed. Therefore, patients are typically cautioned to be aware of how the medication affects them personally before performing tasks that require full attention.

Q: Is Beneum available over-the-counter in any country?

The oral forms of the active ingredient (tablet/capsule) are typically available for purchase without a prescription. However, the injectable solution used in acute deficiency cases requires a prescription.

Q: What is the shelf life of Beneum?

Official labeling mandates that the product must be marked with an expiration date based on stability testing performed by the manufacturer. For many standard tablet formulations, a shelf life of at least 24 months is specified, provided the product is stored according to instructions.

Q: What is the risk of dependence or addiction with Beneum?

Regulatory and authoritative documents regarding this essential nutrient do not list any risk of dependence or addiction. This is consistent with its classification as a B-complex vitamin.

Q: Is there an official patient information leaflet for Beneum?

Yes, official regulatory requirements mandate that all approved drug products are accompanied by an official Patient Information Leaflet, Medication Guide, or similar document. This leaflet details key safety and usage information for patients.

Q: What official documents describe the clinical trials for Beneum?

Information summarizing the clinical trials used to establish the drug’s profile is contained within the official regulatory documents. This summary can typically be found in the Clinical Pharmacology or Clinical Trials sections of the label, such as the FDA Prescribing Information or EMA SmPC.

Q: Does Beneum change the effectiveness of birth control pills?

Official information indicates that the active ingredient does not directly change the effectiveness of hormonal birth control pills. However, if the drug causes an adverse effect like severe diarrhea, the effectiveness of oral contraceptive pills may be potentially reduced due to absorption issues.

Q: Why might a patient need to stop Beneum treatment?

Official documents indicate that if a patient experiences signs of hypersensitivity, which is a severe allergic reaction, official guidance states treatment discontinuation is necessary. Discontinuation is also necessary if a patient develops severe hepatic impairment, which is a formal contraindication.

Q: Is Beneum a medication that needs to be taken at the same time every day?

While the official dosing schedule defines the frequency, authoritative patient information suggests that taking the medication at the same time(s) each day may help a patient maintain the regular dosing schedule and aid in adherence.

Q: What happens if a person takes too much Beneum?

In the event of a suspected overdose, official patient safety information typically describes the need for immediate emergency medical evaluation. This may involve contacting a poison control center or visiting an emergency department for guidance.

Q: Does Beneum interact with herbal teas or natural remedies?

Regulatory information specifies that a healthcare provider should be informed of all products being taken, including herbal products and natural remedies. This is to ensure safe use and check for potential interactions.

How should Beneum be stored and disposed of?

Beneum (Thiamine Hydrochloride) must be stored strictly according to the conditions defined in the official labeling to maintain its stability. The medicine must be kept in its original container and protected from light and moisture. It should be stored in a dry place at a controlled temperature, typically not exceeding 30 C (86 F).

To ensure safety, Beneum must be stored out of the sight and reach of children and pets, and the safety cap must remain tightly closed. Do not use the product past the expiration date printed on the package.

For disposal of unused or expired medicine, do not throw it away via household waste or wastewater. The officially recommended methods are to utilize a community drug take-back program or mail-back service. If these are unavailable, mix the medicine with an undesirable substance, seal it in a bag, and place it in the trash, following all local environmental regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Beneum found in:

A-Z Index: